-+ 0.00%
-+ 0.00%
-+ 0.00%

AVALO THERAPEUTICS SHARES DOWN 37% AFTER RIVAL ABBVIE REPORTS SKIN DRUG TRIAL DATA

Reuters·10/22/2026 15:33:08

Please log in to view news